Description
Cerebrolysin is an injectable neuropeptide preparation derived from purified pig brain proteins. It is commonly used in Eastern Europe and Asia to treat stroke, dementia, and traumatic brain injury.
What Is It?
Cerebrolysin is a proprietary mixture of biologically active peptides (about 80%) and free amino acids (about 20%). Its composition mimics naturally occurring neurotrophic factors (like BDNF, NGF, and CNTF). It is believed to act as a neuroprotectant by preventing brain cell death, reducing neuroinflammation, and stimulating the brain’s ability to heal and form new connections.
Approved Uses & Research
In dozens of Eurasian countries, the drug is prescribed as an adjunctive therapy for several neurological conditions:
- Stroke: Studied to reduce brain damage and support functional recovery, particularly when administered in the subacute or acute phases.
- Dementia: Prescribed to improve cognitive and physical function in patients with Alzheimer’s disease and vascular dementia.
- Traumatic Brain Injury (TBI): Used in the hospital setting to help improve clinical outcomes.
Reviews
There are no reviews yet.